IonQ Other Income (Expense) decreased by 2321.3% to -$16.13M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 31721.6%, from $51.00K to -$16.13M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows relatively stable performance with a 0.9% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00K | $2.00K | $21.00K | $1.00K | -$46.00K | $20.00K | $33.00K | $64.00K | $31.00K | $55.00K | -$235.00K | -$134.00K | -$45.00K | $15.00K | -$111.00K | $51.00K | $232.00K | -$980.00K | $726.00K | -$16.13M |
| QoQ Change | — | +0.0% | +950.0% | -95.2% | <-999% | +143.5% | +65.0% | +93.9% | -51.6% | +77.4% | -527.3% | +43.0% | +66.4% | +133.3% | -840.0% | +145.9% | +354.9% | -522.4% | +174.1% | <-999% |
| YoY Change | — | — | — | — | <-999% | +900.0% | +57.1% | >999% | +167.4% | +175.0% | -812.1% | -309.4% | -245.2% | -72.7% | +52.8% | +138.1% | +615.6% | <-999% | +754.1% | <-999% |